{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:49:31Z","timestamp":1791038971962,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2006,10,27]],"date-time":"2006-10-27T00:00:00Z","timestamp":1161907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s00330-006-0425-9","type":"journal-article","created":{"date-parts":[[2006,10,26]],"date-time":"2006-10-26T08:53:09Z","timestamp":1161852789000},"page":"1700-1713","source":"Crossref","is-referenced-by-count":63,"title":["The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients"],"prefix":"10.1007","volume":"17","author":[{"given":"Martijn R.","family":"Meijerink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"van Cruijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Hoekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Kater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cors","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Hein T. M.","family":"van Waesberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu A.","family":"Manoliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,27]]},"reference":[{"key":"425_CR1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182\u20131186","journal-title":"N Engl J Med"},{"key":"425_CR2","first-page":"48","volume-title":"WHO Handbook for reporting results of cancer treatment","author":"World Health Organisation","year":"1979","unstructured":"World Health Organisation (1979) WHO Handbook for reporting results of cancer treatment. World Health Organisation, Geneva, Switzerland, p 48"},{"key":"425_CR3","volume-title":"A practical guide to EORTC studies","author":"J Hawthorn","year":"1994","unstructured":"Hawthorn J (1994) A practical guide to EORTC studies. European Organisation for the Research and Treatment of Cancer (EORTC), Brussels"},{"key":"425_CR4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer 92:205\u2013216","journal-title":"J Natl Cancer"},{"key":"425_CR5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0140-6736(91)92455-B","volume":"337","author":"KA Miles","year":"1991","unstructured":"Miles KA, Hayball M, Dixon AK (1991) Colour perfusion imaging: a new application of computed tomography. Lancet 337:643\u2013645","journal-title":"Lancet"},{"key":"425_CR6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1259\/0007-1285-64-761-409","volume":"64","author":"KA Miles","year":"1991","unstructured":"Miles KA (1991) Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol 64:409\u2013412","journal-title":"Br J Radiol"},{"key":"425_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiology.214.1.r00ja1473","volume":"214","author":"SJ Swensen","year":"2000","unstructured":"Swensen SJ, Viggiano RW, Midthun DE, Muller NL, Sherrick A, Yamashita K, Naidich DP, Patz EF, Hartman TE, Muhm JR, Weaver AL (2000) Lung nodule enhancement at CT: multicenter study. Radiology 214:73\u201380","journal-title":"Radiology"},{"key":"425_CR8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1148\/radiology.205.2.9356631","volume":"205","author":"M Zhang","year":"1997","unstructured":"Zhang M, Kono M (1997) Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 205:471\u2013478","journal-title":"Radiology"},{"key":"425_CR9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1148\/radiology.205.3.9393526","volume":"205","author":"DA Leggett","year":"1997","unstructured":"Leggett DA, Kelley BB, Bunce IH, Miles KA (1997) Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology 205:716\u2013720","journal-title":"Radiology"},{"key":"425_CR10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00004728-199907000-00010","volume":"23","author":"PE Dugdale","year":"1999","unstructured":"Dugdale PE, Miles KA, Bunce I, Kelley BB, Leggett DA (1999) CT measurements of perfusion and permeability within lymphoma masses and its ability to assess grade, activity and chemotherapeutic response. J Compu Assist Tomogr 23:540\u2013547","journal-title":"J Compu Assist Tomogr"},{"key":"425_CR11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1259\/bjr.71.843.9616236","volume":"71","author":"KA Miles","year":"1998","unstructured":"Miles KA, Leggett DAC, Kelley BB, Hayball MP, Sinnatamby R, Bunce I (1998) In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol 71:276\u2013281","journal-title":"Br J Radiol"},{"key":"425_CR12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0360-3016(03)00764-8","volume":"57","author":"R Hermans","year":"2003","unstructured":"Hermans R, Meijerink M, Van den Bogaert W, Rijnders A, Weltens C, Lambin P (2003) Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 57:1351\u20131356","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"425_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","volume":"10","author":"CG Willett","year":"2004","unstructured":"Willett CG, Boucher Y, di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145\u2013147","journal-title":"Nat Med"},{"key":"425_CR14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1023\/B:DRUG.0000036688.96453.8d","volume":"22","author":"HQ Xiong","year":"2004","unstructured":"Xiong HQ, Herbst R, Faria SC, Scholz C, Davis D, Jackson EF, Madden T, McConkey D, Hicks M, Hess K, Charnsangavej C, Abbruzzese JL (2004) A phase I surrogate endpoint study of SU6668 in patients with solid tumors. Invest New Drugs 22:459\u2013466","journal-title":"Invest New Drugs"},{"key":"425_CR15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1200\/JCO.2003.12.120","volume":"21","author":"JP Thomas","year":"2003","unstructured":"Thomas JP, Arzoomanian RZ, Alberti D, Marnocha R, Lee F, Friedl A, Tutsch K, Dresen A, Geiger P, Pluda J, Fogler W, Schiller JH, Wilding G (2003) Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol 21:223\u2013231","journal-title":"J Clin Oncol"},{"key":"425_CR16","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1158\/0008-5472.CAN-04-4409","volume":"65","author":"SR Wedge","year":"2005","unstructured":"Wedge SR, Kendrew J, Hennequin LF, Valentine PJ, Barry ST, Brave SR, Smith NR, James NH, Dukes M, Curwen JO, Chester R, Jackson JA, Boffey SJ, Kilburn LL, Barnett S, Richmond GH, Wadsworth PF, Walker M, Bigley AL, Taylor ST, Cooper L, Beck S, Jurgensmeier JM, Ogilvie DJ (2005) AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res 65:4389\u20134400","journal-title":"Cancer Res"},{"key":"425_CR17","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.2003.10.038","volume":"21","author":"M Fukuoka","year":"2003","unstructured":"Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP, Baselga J (2003) Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial). J Clin Oncol 21:2237\u20132246","journal-title":"J Clin Oncol"},{"key":"425_CR18","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","volume":"290","author":"MG Kris","year":"2003","unstructured":"Kris MG, Natale RB, Herbst RS, Lynch TJ Jr, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis H, Sandler A, Albain KS, Cella D, Wolf MK, Averbuch SD, Ochs JJ, Kay AC (2003) Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA 290:2149\u20132158","journal-title":"JAMA"},{"key":"425_CR19","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1158\/0008-5472.CAN-04-4409","volume":"65","author":"SR Wedge","year":"2005","unstructured":"Wedge SR, Kendrew J, Hennequin LF (2005) AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res 65:4389\u20134400","journal-title":"Cancer Res"},{"key":"425_CR20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"425_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1076-6332(03)00578-6","volume":"11","author":"Y Tsushima","year":"2004","unstructured":"Tsushima Y, Funabasama S, Aoki J, Sanada S, Endo K (2004) Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 11:215\u2013223","journal-title":"Acad Radiol"},{"key":"425_CR22","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1076-6332(03)80462-2","volume":"9","author":"Y Tsushima","year":"2002","unstructured":"Tsushima Y, Funabasama S, Sanada S, Aoki J, Endo K (2002) Development of perfusion CT software for personal computers. Acad Radiol 9:922\u2013926","journal-title":"Acad Radiol"},{"key":"425_CR23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1148\/radiology.188.2.8327686","volume":"188","author":"KA Miles","year":"1993","unstructured":"Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405\u2013411","journal-title":"Radiology"},{"key":"425_CR24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1076-6332(03)80370-7","volume":"9","author":"Y Tsushima","year":"2002","unstructured":"Tsushima Y, Blomley MJ, Kusano S, Endo K (2002) Measuring portal venous perfusion with contrast-enhanced CT: comparison of direct and indirect methods. Acad Radiol 9:276\u2013282","journal-title":"Acad Radiol"},{"key":"425_CR25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1095-0397(00)00063-7","volume":"3","author":"N Mullani","year":"2000","unstructured":"Mullani N, Herbst R, Abbruzzese J, Charnsangavej C, Kim E, Tran H, Barron B, Lamki L, Gould K (2000) Antiangiogenic treatment with endostatin results in uncoupling of blood flow and glucose metabolism in human tumors. Clin Positron Imaging 3:151","journal-title":"Clin Positron Imaging"},{"key":"425_CR26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/nbm.754","volume":"15","author":"RJ Maxwell","year":"2002","unstructured":"Maxwell RJ, Wilson J, Prise VE, Vojnovic B, Rustin GJ, Lodge MA, Tozer GM (2002) Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI. NMR Biomed 15:89\u201398","journal-title":"NMR Biomed"},{"key":"425_CR27","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1200\/JCO.2005.09.034","volume":"23","author":"AL Thomas","year":"2005","unstructured":"Thomas AL, Morgan B, Horsfield MA, Higginson A, Kay A, Lee L, Masson E, Puccio-Pick M, Laurent D, Steward WP (2005) Phase I study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PTK787\/ZK 222584 administered twice daily in patients with advanced cancer. J Clin Oncol 23:4162\u20134171","journal-title":"J Clin Oncol"},{"key":"425_CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1158\/1078-0432.CCR-05-0219","volume":"12","author":"KD Miller","year":"2006","unstructured":"Miller KD, Miller M, Mehrotra S, Agarwal B, Mock BH, Zheng QH, Badve S, Hutchins GD, Sledge GW Jr (2006) A physiologic imaging pilot study of breast cancer treated with AZD2171. Clin Cancer Res 12:281\u2013288","journal-title":"Clin Cancer Res"},{"key":"425_CR29","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1023\/A:1011990226667","volume":"46","author":"Y Tsushima","year":"2001","unstructured":"Tsushima Y, Blomley MJ, Yokoyama H, Kusano S, Endo K (2001) Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver? Dig Dis Sci 46:2113\u20132119","journal-title":"Dig Dis Sci"},{"key":"425_CR30","unstructured":"van Cruijsen H, Voest EE, van Herpen CM, Hoekman K, Witteveen PO, Punt CJ, Puchalski TA, Fernandes N, Koehler M, Giaccone G (2005) Phase I evaluation of AZD2171 in combination with gefinitib (Iressa) in patients with advanced tumours. Proc Am Soc Clin Oncol Abstract 3030"},{"key":"425_CR31","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/sj.bjc.6602550","volume":"92","author":"MO Leach","year":"2005","unstructured":"Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P; Pharmacodynamic\/Pharmacokinetic Technologies Advisory Committee, Drug Development Office, Cancer Research UK (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 92:1599\u20131610","journal-title":"Br J Cancer"},{"key":"425_CR32","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/1097-0142(19870501)59:9<1547::AID-CNCR2820590903>3.0.CO;2-6","volume":"59","author":"JA Ridge","year":"1987","unstructured":"Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly JM (1987) Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer 59:1547\u20131553","journal-title":"Cancer"},{"key":"425_CR33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1148\/radiol.2312030160","volume":"231","author":"JB Kruskal","year":"2004","unstructured":"Kruskal JB, Thomas P, Kane RA, Goldberg SN (2004) Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 231:482\u2013490","journal-title":"Radiology"},{"key":"425_CR34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1259\/bjr.71.843.9616236","volume":"71","author":"KA Miles","year":"1998","unstructured":"Miles KA, Leggett DA, Kelley BB, Hayball MP, Sinnatamby R, Bunce I (1998) In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol 71:276\u2013281","journal-title":"Br J Radiol"},{"key":"425_CR35","first-page":"416","volume":"38","author":"T Irie","year":"1997","unstructured":"Irie T, Tsushima Y, Terahata S, Hatsuse K, Kusano S, Itai Y (1997) Rim enhancement in colorectal metastases at CT during infusion hepatic arteriography. Does it represent liver parenchyma or live tumor cell zone? Acta Radiol 38:416\u2013421","journal-title":"Acta Radiol"},{"key":"425_CR36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00004728-199505000-00016","volume":"19","author":"MJ Blomley","year":"1995","unstructured":"Blomley MJ, Coulden R, Dawson P, Kormano M, Donlan P, Bufkin C, Lipton MJ (1995) Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 19:424\u2013433","journal-title":"J Comput Assist Tomogr"},{"key":"425_CR37","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1023\/A:1026679430553","volume":"44","author":"Y Tsushima","year":"1999","unstructured":"Tsushima Y, Blomley MJ, Kusano S, Endo K (1999) The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci 44:1632\u20131638","journal-title":"Dig Dis Sci"},{"key":"425_CR38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58\u201362","journal-title":"Science"},{"key":"425_CR39","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2004.10.011","volume":"6","author":"F Winkler","year":"2004","unstructured":"Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E, Munn LL, Jain RK (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6:553\u2013563","journal-title":"Cancer Cell"},{"key":"425_CR40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1148\/radiology.210.1.r99ja46269","volume":"210","author":"G Brix","year":"1999","unstructured":"Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W (1999) Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT-initial experience. Radiology 210:269\u2013276","journal-title":"Radiology"},{"key":"425_CR41","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1148\/radiol.2343031362","volume":"234","author":"PV Pandharipande","year":"2005","unstructured":"Pandharipande PV, Krinsky GA, Rusinek H, Lee VS (2005) Perfusion imaging of the liver: current challenges and future goals. Radiology 234:661\u2013673","journal-title":"Radiology"},{"key":"425_CR42","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/bjc.1983.111","volume":"47","author":"SH Leveson","year":"1983","unstructured":"Leveson SH, Wiggins PA, Nasiru TA, Giles GR, Robinson PJ, Parkin A (1983) Improving the detection of hepatic metastases by the use of dynamic flow scintigraphy. Br J Cancer 47:719\u2013721","journal-title":"Br J Cancer"},{"key":"425_CR43","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.ultrasmedbio.2004.08.011","volume":"30","author":"M Krix","year":"2004","unstructured":"Krix M, Plathow C, Kiessling F, Herth F, Karcher A, Essig M, Schmitteckert H, Kauczor HU, Delorme S (2004) Quantification of perfusion of liver tissue and metastases using a multivessel model for replenishment kinetics of ultrasound contrast agents. Ultrasound Med Biol 30:1355\u20131363","journal-title":"Ultrasound Med Biol"},{"key":"425_CR44","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1118\/1.595553","volume":"11","author":"MD Harpen","year":"1984","unstructured":"Harpen MD, Lecklitner ML (1984) Derivation of gamma variate indicator dilution function from simple convective dispersion model of blood flow. Med Phys 11:690\u2013692","journal-title":"Med Phys"},{"key":"425_CR45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/mrm.10045","volume":"47","author":"R Materne","year":"2002","unstructured":"Materne R, Smith AM, Peeters F, Dehoux JP, Keyeux A, Horsmans Y, Van Beers BE (2002) Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 47:135\u2013142","journal-title":"Magn Reson Med"},{"key":"425_CR46","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/nbm.729","volume":"15","author":"A Jackson","year":"2002","unstructured":"Jackson A, Haroon H, Zhu XP, Li KL, Thacker NA, Jayson G (2002) Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model. NMR Biomed 15:164\u2013173","journal-title":"NMR Biomed"},{"key":"425_CR47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","volume":"10","author":"PS Tofts","year":"1999","unstructured":"Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223\u2013232","journal-title":"J Magn Reson Imaging"},{"key":"425_CR48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/nbm.732","volume":"15","author":"AR Padhani","year":"2002","unstructured":"Padhani AR, Hayes C, Landau S, Leach MO (2002) Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 15:143\u2013153","journal-title":"NMR Biomed"},{"key":"425_CR49","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2214\/ajr.176.3.1760667","volume":"176","author":"BE Beers Van","year":"2001","unstructured":"Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y (2001) Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. Am J Roentgenol 176:667\u2013673","journal-title":"Am J Roentgenol"},{"key":"425_CR50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jmri.1179","volume":"14","author":"K Turetschek","year":"2001","unstructured":"Turetschek K, Floyd E, Helbich T, Roberts TP, Shames DM, Wendland MF, Carter WO, Brasch RC (2001) MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. J Magn Reson Imaging 14:237\u2013242","journal-title":"J Magn Reson Imaging"},{"key":"425_CR51","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s00330-004-2339-8","volume":"14","author":"LS Fournier","year":"2004","unstructured":"Fournier LS, Cuenod CA, de Bazelaire C, Siauve N, Rosty C, Tran PL, Frija G, Clement O (2004) Early modifications of hepatic perfusion measured by functional CT in a rat model of hepatocellular carcinoma using a blood pool contrast agent. Eur Radiol 14:2125\u20132133","journal-title":"Eur Radiol"},{"key":"425_CR52","first-page":"1","volume":"3","author":"SS Kety","year":"1951","unstructured":"Kety SS (1951) The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 3:1\u201341","journal-title":"Pharmacol Rev"},{"key":"425_CR53","first-page":"228","volume":"8","author":"SS Kety","year":"1960","unstructured":"Kety SS (1960) Theory of blood-tissue exchange and its application to measurement of blood flow. Methods Med Res 8:228\u2013236","journal-title":"Methods Med Res"},{"key":"425_CR54","first-page":"6350","volume":"9","author":"P Wells","year":"2003","unstructured":"Wells P, Jones T, Price P (2003) Assessment of inter- and intra-patient variability in C15O2 positron emission tomography measurements of blood flow in patients with intra-abdominal cancers. Clin Cancer Res 9:6350\u20136356","journal-title":"Clin Cancer Res"},{"key":"425_CR55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002590000410","volume":"28","author":"MA Flower","year":"2001","unstructured":"Flower MA, Zweit J, Hall AD, Burke D, Davies MM, Dworkin MJ, Young HE, Mundy J, Ott RJ, McCready VR, Carnochan P, Allen-Mersh TG (2001) 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Eur J Nucl Med 28:99\u2013103","journal-title":"Eur J Nucl Med"},{"key":"425_CR56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jnci\/dji023","volume":"97","author":"JC Miller","year":"2005","unstructured":"Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH (2005) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97:172\u2013187","journal-title":"J Natl Cancer Inst"},{"key":"425_CR57","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/cs0990517","volume":"99","author":"R Materne","year":"2000","unstructured":"Materne R, Van Beers BE, Smith AM, Leconte I, Jamart J, Dehoux JP, Keyeux A, Horsmans Y (2000) Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 99:517\u2013525","journal-title":"Clin Sci (Lond)"},{"key":"425_CR58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1148\/radiology.137.3.7003648","volume":"137","author":"L Axel","year":"1980","unstructured":"Axel L (1980) Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. Radiology 137:679\u2013686","journal-title":"Radiology"},{"key":"425_CR59","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1161\/01.STR.22.6.768","volume":"22","author":"GT Gobbel","year":"1991","unstructured":"Gobbel GT, Cann CE, Fike JR (1991) Measurement of regional cerebral blood flow using ultrafast computed tomography. Theoretical aspects. Stroke 22:768\u2013771","journal-title":"Stroke"},{"key":"425_CR60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1148\/radiology.213.1.r99oc03141","volume":"213","author":"DG Nabavi","year":"1999","unstructured":"Nabavi DG, Cenic A, Craen RA, Gelb AW, Bennett JD, Kozak R, Lee TY (1999) CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 213:141\u2013149","journal-title":"Radiology"},{"key":"425_CR61","first-page":"462","volume":"21","author":"A Cenic","year":"2000","unstructured":"Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY (2000) A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. Am J Neuroradiol 21:462\u2013470","journal-title":"Am J Neuroradiol"},{"key":"425_CR62","first-page":"1226","volume":"14","author":"F Kiessling","year":"2004","unstructured":"Kiessling F, Boese J, Corvinus C, Ederle JR, Zuna I, Schoenberg SO, Brix G, Schmahl A, Tuengerthal S, Herth F, Kauczor HU, Essig M (2004) Perfusion CT in patients with advanced bronchial carcinomas: a novel chance for characterization and treatment monitoring? Eur Radiol 14:1226\u20131233","journal-title":"Eur Radiol"},{"key":"425_CR63","first-page":"577","volume":"24","author":"NA Mullani","year":"1983","unstructured":"Mullani NA, Gould KL (1983) First-pass measurements of regional blood flow with external detectors. J Nucl Med 24:577\u2013581","journal-title":"J Nucl Med"},{"key":"425_CR64","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1259\/bjr.74.882.740552","volume":"74","author":"JH Gillard","year":"2001","unstructured":"Gillard JH, Antoun NM, Burnet NG, Pickard JD (2001) Reproducibility of quantitative CT perfusion imaging. Br J Radiol 74:552\u2013555","journal-title":"Br J Radiol"},{"key":"425_CR65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1076-6332(97)80155-9","volume":"4","author":"MJ Blomley","year":"1997","unstructured":"Blomley MJ, Kormano M, Coulden R, Lim-Dunham J, Dawson P, Lipton MJ (1997) Splenic blood flow: evaluation with computed tomography. Acad Radiol 4:13\u201320","journal-title":"Acad Radiol"},{"key":"425_CR66","first-page":"1","volume":"31","author":"ICRP Publication 60","year":"1991","unstructured":"ICRP Publication 60 (1991) 1990 Recommendations of the International Commission on Radiological Protection. Ann ICRP 31:1\u20133","journal-title":"Ann ICRP"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-006-0425-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-006-0425-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-006-0425-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:53:25Z","timestamp":1559030005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-006-0425-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,27]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1007\/s00330-006-0425-9","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,27]]}}}